Total Payments
$1,834
2024 Payments
$454.84
Companies
15
Transactions
86
Medicare Patients
1,516
Medicare Billing
$540,554
Payment Breakdown by Category
Food & Beverage$1,430 (78.0%)
Other$350.00 (19.1%)
Consulting$40.00 (2.2%)
Education$13.89 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,430 | 83 | 78.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $350.00 | 1 | 19.1% |
| Consulting Fee | $40.00 | 1 | 2.2% |
| Education | $13.89 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $557.70 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $282.45 | 24 | $0 (2022) |
| Horizon Pharma plc | $242.35 | 7 | $0 (2018) |
| UCB, Inc. | $180.04 | 11 | $0 (2021) |
| Lilly USA, LLC | $136.19 | 7 | $0 (2020) |
| GlaxoSmithKline, LLC. | $98.55 | 4 | $0 (2021) |
| PFIZER INC. | $78.12 | 5 | $0 (2019) |
| Amgen Inc. | $76.50 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $44.88 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $35.13 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.84 | 6 | ABBVIE INC. ($416.14) |
| 2022 | $44.10 | 3 | ABBVIE INC. ($17.12) |
| 2021 | $158.34 | 8 | UCB, Inc. ($42.82) |
| 2020 | $94.48 | 5 | Lilly USA, LLC ($46.81) |
| 2019 | $290.96 | 15 | UCB, Inc. ($112.27) |
| 2018 | $393.17 | 30 | Janssen Biotech, Inc. ($169.21) |
| 2017 | $397.80 | 19 | Horizon Pharma plc ($205.27) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Bone Health | ||||||
| 06/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.15 | General |
| 02/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.35 | General |
| 02/19/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.38 | General |
| 07/18/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology | ||||||
| 05/05/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Immunology | ||||||
| 03/16/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 02/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Immunology | ||||||
| 11/10/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 10/07/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Immunology | ||||||
| 02/21/2020 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Immunology | ||||||
| 11/05/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 10/15/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 10/15/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 360 | 2,532 | $215,075 | $75,947 |
| 2022 | 11 | 391 | 3,740 | $267,224 | $97,035 |
| 2021 | 9 | 354 | 3,995 | $270,230 | $96,040 |
| 2020 | 13 | 411 | 30,973 | $598,015 | $271,532 |
Total Patients
1,516
Total Services
41,240
Medicare Billing
$540,554
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,380 | $46,023 | $25,343 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 343 | $68,600 | $23,766 | 34.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 137 | $12,330 | $7,101 | 57.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $16,650 | $5,629 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 56 | $13,650 | $5,348 | 39.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 36 | 102 | $35,700 | $5,261 | 14.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 206 | $14,832 | $2,367 | 16.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 39 | 178 | $5,340 | $850.83 | 15.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 17 | $680.00 | $153.04 | 22.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 17 | $680.00 | $98.74 | 14.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 11 | 59 | $590.00 | $30.12 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 390 | $78,000 | $26,940 | 34.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,440 | $48,024 | $24,605 | 51.2% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2022 | 12 | 1,140 | $28,500 | $15,567 | 54.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 23 | 176 | $15,840 | $9,430 | 59.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 47 | 47 | $21,150 | $8,109 | 38.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 45 | 123 | $43,050 | $6,235 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 31 | $7,610 | $2,768 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 193 | $13,896 | $2,295 | 16.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 42 | 166 | $8,820 | $848.78 | 9.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 14 | 19 | $1,384 | $159.14 | 11.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 11 | 15 | $950.00 | $77.80 | 8.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 348 | $67,960 | $24,505 | 36.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 13 | 1,500 | $50,025 | $24,423 | 48.8% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2021 | 11 | 1,380 | $34,500 | $18,932 | 54.9% |
About Dr. Judith Frank, MD
Dr. Judith Frank, MD is a Rheumatology healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407929144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith Frank, MD has received a total of $1,834 in payments from pharmaceutical and medical device companies, with $454.84 received in 2024. These payments were reported across 86 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,430).
As a Medicare-enrolled provider, Frank has provided services to 1,516 Medicare beneficiaries, totaling 41,240 services with total Medicare billing of $540,554. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Melrose Park, IL
- Active Since 11/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1407929144
Products in Payments
- RINVOQ (Biological) $451.43
- SIMPONI ARIA (Biological) $241.26
- KRYSTEXXA (Drug) $226.08
- Cimzia (Drug) $180.04
- BENLYSTA (Biological) $98.55
- FORTEO (Drug) $69.83
- TALTZ (Drug) $66.36
- XELJANZ (Drug) $54.60
- Humira (Biological) $51.04
- Enbrel (Biological) $39.06
- ORENCIA (Biological) $35.13
- DUZALLO (Drug) $32.22
- COSENTYX (Biological) $24.73
- HUMIRA (Biological) $23.59
- EVENITY (Biological) $23.55
- INFLECTRA (Biological) $23.52
- RINVOQ (Drug) $20.14
- RAYOS (Drug) $16.27
- Rituxan (Biological) $16.15
- Hymovis (Device) $15.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.